A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).

MLA

Tomita, Noriko, et al. “A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).” Life (2075-1729), vol. 12, no. 6, June 2022, p. 856. EBSCOhost, https://doi.org/10.3390/life12060856.

APA

Tomita, N., Saito, S., Terada-Hirashima, J., Mikami, A., Uemura, Y., Kutsuna, S., Nomoto, H., Fujisawa, K., Nagashima, M., Terada, M., Ashida, S., Morioka, S., Satake, M., Hangaishi, A., Togano, T., Shiratori, K., Takamatsu, Y., Maeda, K., Ohmagari, N., & Sugiura, W. (2022). A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). Life (2075-1729), 12(6), 856. https://doi.org/10.3390/life12060856

Chicago

Tomita, Noriko, Sho Saito, Junko Terada-Hirashima, Ayako Mikami, Yukari Uemura, Satoshi Kutsuna, Hidetoshi Nomoto, et al. 2022. “A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).” Life (2075-1729) 12 (6): 856. doi:10.3390/life12060856.